InsightAce.jpg
Smart/AI In-Vitro Diagnostics Market 2023 | Exclusive Report on the Latest Revenue and Future Scope - InsightAce Analytic
May 04, 2023 09:30 ET | InsightAce Analytic Pvt. LTd.
Jersey City, NJ, May 04, 2023 (GLOBE NEWSWIRE) -- According to the latest research by InsightAce Analytic, the global Smart or AI In-Vitro Diagnostics Market size is valued at US$ 1.23 Billion in...
MaximizeMarketResearch
In-Vitro Diagnostics Market to grow at a CAGR of 3.41 percent during the forecast period, Latest Advancements and Regional Insights
March 10, 2023 04:30 ET | MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
New York, US, March 10, 2023 (GLOBE NEWSWIRE) -- A global Healthcare business-consulting firm, Maximize Market research, has published a market intelligence and competitive landscape report on the...
AIMLogo.jpg
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
November 03, 2014 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
New Life Agency
In the Face of Healthcare Reform, New Life Agency Offers Added IVF Resources and Savings
November 15, 2012 10:30 ET | New Life Agency
Rancho Mirage, CA, Nov. 15, 2012 (GLOBE NEWSWIRE) -- New Life Agency is pleased to announce the addition of Island Reproductive Services to their cutting-edge Assisted Reproduction Insurance...